A molecular link between dystonia 1 and dystonia 6?

Annals of Neurology

Volumn 68, Issue 4, 2010, Pages 418-420

  Müller, Ulrich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR THAP1; TRINUCLEOTIDE; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CHAPERONE; DNA BINDING PROTEIN; NUCLEAR PROTEIN; THAP1 PROTEIN, HUMAN; TOR1A PROTEIN, HUMAN;

CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DYSTONIA; EDITORIAL; ENDOTHELIUM CELL; EXON; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC DISORDER; GENETIC LINKAGE; HELA CELL; IN VIVO STUDY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; ANIMAL; GENETICS; HUMAN; METABOLISM; MOUSE; MUTATION; NOTE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; DNA-BINDING PROTEINS; DYSTONIA; HUMANS; MICE; MOLECULAR CHAPERONES; MUTATION; NUCLEAR PROTEINS;

EID: 78149475753     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22183     Document Type: Editorial

References (26)

1. Müller U., The monogenic primary dystonias. Brain 2009; 132: 2005 2025.
2. Albanese A, Asmus F, Bhatia KP, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 2010 (in press). DOI: 10.1111/j. 1468-.2010.03042.x.
3. Gavarini S, Cayrol C, Fuchs T, et al. A direct interaction between causative genes of DYT1 and DYT6 primary dystonia. Ann Neurol 2010; 68: 456 461.
4. Kaiser FJ, Osmanovic A, Rakovic A, et al. The dystonia gene DYT1 is repressed by the transcription factor THAP1 (DYT6). Ann Neurol 2010; 68: 462 468.
5. Ozelius LJ, Hewett JW, Page CE, et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997; 17: 40 48.
6. Bessière D, Lacroix C, Campagne S, et al. Structure-function analysis of the THAP zinc finger of THAP1, a large C2CH DNA-binding module linked to Rb/E2F pathways. J Biol Chem 2008; 283: 4352 4363.
7. Cayrol C, Lacroix C, Mathe C, et al. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cellcycle target genes. Blood 2007; 109: 584 594.
8. Roussigne M, Cayrol C, Clouaire T, et al. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies. Oncogene 2003; 22: 2432 2442.
9. Clouaire T, Roussigne M, Ecochard V, et al. The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity. Proc Natl Acad Sci U S A 2005; 102: 6907 6912.
10. Sabogal A, Lyubimov AY, Corn JE, et al. THAP proteins target specific DNA sites through bipartite recognition of adjacent major and minor grooves. Nat Struct Mol Biol 2010; 17: 117 124.
11. Dang MT, Yokoi F, Pence MA, Li Y., Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci Res 2006; 56: 470 474.
12. Dang MT, Yokoi F, McNaught KS, et al. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp Neurol 2005; 196: 452 463.
13. Goodchild RE, Kim CE, Dauer ET., Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005; 48: 923 932.
14. Grundmann K, Reischmann B, Vanhoutte G, et al. Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol Dis 2007; 27: 190 206.
15. Mazars R, Gonzales-de-Peredo A, Cayrol C, et al. The THAP-Zinc finger protein THAP1 associates with coactivator HCF-1 and 0-GLcNAc transferase. J Biol Chem 2010; 285: 13364 13371.
16. Herzfeld T, Nolte D, Müller U., Structural and functional analysis of the human TAF1/DYT3 multiple transcript system. Mamm Genome 2007; 18: 787 795.
17. Nolte D, Niemann S, Müller U., Specific sequence changes in multiple transcript system DYT3 are associated with X-linked dystonia parkinsonism. Proc Natl Acad Sci U S A 2003; 100: 10347 10352.
18. Fuchs T, Gavarini S, Saunders-Pullman R, et al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 2009; 3: 286 288.
19. Bressman SB, Fuchs T, Heimann GA, et al. Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol 2009; 8; 441 446.
20. Djarmati A, Schneider SA, Lohmann K, et al. Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study. Lancet Neurol 2009; 8: 447 452.
21. Paisán-Ruiz C, Ruiz-Martinez J, Ruibal M, et al. Identification of a novel THAP1 mutation at R29 amino-acid residue in sporadic patients with early-onset dystonia. Mov Disord 2009; 24: 2428 2443.
22. Bonetti M, Barzaghi C, Brancati F, et al. Mutation screening of the DYT6/THAP1 gene in Italy. Mov Disord 2009; 24: 2424 2427.
23. Houlden H, Schneider SA, Paudel R, et al. THAP1 mutations (DYT6) are an additional cause of early-onset dystonia. Neurology 2010; 74: 846 850.
24. Xiao J, Zhao Y, Bastian RW, et al. Novel THAP1 sequence variants in primary dystonia. Neurology 2010; 74: 229 238.
25. Söhn AS, Glöckle N, Doetzer AD, et al. Prevalence of THAP1 mutations in a large cohort of German patients with primary dystonia. Mov Disord (in press). DOI: 10.1002/mds.23207.
26. Human Genome Variation Society. Discussions regarding the description of sequence variants. Available at: Accessed August 14, 2010.